In light of hypocalcemia in COVID-19 patients and its association with hypoparathyroidism (39, 40), we detected significant levels of the anti-CaSR antibody (calcium receptor) in LC cohort (Figure 6K). This evidence concerns the gene CASR and laryngotracheoesophageal cleft.